GLP3-Reta (20mg)
GLP-1R refers to a research compound targeting the glucagon-like peptide-1 receptor pathway, investigated extensively for its effects on appetite signaling, insulin response, and gastric emptying.
About GLP-1R
GLP-1R designates a research peptide targeting the glucagon-like peptide-1 (GLP-1) receptor. The GLP-1 receptor pathway has been one of the most extensively investigated targets in metabolic research over the past two decades, with literature spanning insulin secretion, gastric motility, appetite regulation, and downstream metabolic effects.
Mechanism in Research Literature
GLP-1 receptor activation has been documented to:
- Stimulate glucose-dependent insulin secretion from pancreatic beta cells
- Suppress glucagon release in a glucose-dependent manner
- Delay gastric emptying
- Reduce appetite signaling in central nervous system models
- Affect food-reward and food-seeking pathways in research literature
Research Context
GLP-1 receptor agonists have been investigated in studies exploring:
- Glucose homeostasis and insulin response
- Body weight and adipose tissue research
- Cardiovascular and lipid-handling research
- Comparative pharmacology between single- and dual-receptor agonists
- Pharmacokinetic optimization across different molecular formats
Related Research Peptides
GLP-1R appears in literature alongside GLP-1S (single-receptor) and GLP-1T (dual GLP-1/GIP receptor) compounds, as well as broader metabolic research peptides including AOD-9604, Tesamorelin, 5-Amino-1MQ, and MOTS-c.
